Dexcom | Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
Align Technology USD 0 0 2024-12
AtriCure USD 61.86M 0 2025-12
Avanos Medical USD 90.3M 3.1M 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 10.99B 12M 2025-09
Cooper Companies USD 2.46B 26.1M 2025-09
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 598.2M 200K 2025-09
Globus Medical USD 427K 254K 2025-09
Hologic USD 2.5B 2.1M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
J&J USD 39.44B 30M 2025-12
Masimo USD 559.1M 39.6M 2025-09
Medtronic USD 27.62B 1.45B 2025-09
Merit Medical Systems USD 734.04M 1.12M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Solventum Corp USD 5.14B 2.68B 2025-09
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
West Pharmaceutical Services USD 202.8M 100K 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12


Dexcom Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.